SRPT, 3/5-4/15, -2% Loss

BATS:SRPT   Sarepta Therapeutics, Inc.
I’m n 2/28/2024, Sarepta Therapeutics (SRPT) reported earnings of $0.51 per share on revenue of $396.78 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.01 per share on revenue of $384.54 million.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.